MIR141 Expression Differentiates Hashimoto Thyroiditis from PTC and Benign Thyrocytes in Irish Archival Thyroid...

Area of Science:

• Molecular Biology
• Oncology
• Endocrinology

Background:

• MicroRNAs (miRNAs) are crucial gene expression regulators, with dysregulation linked to human oncogenesis.
• A specific miRNA signature, including MIR141, previously differentiated papillary thyroid cancer (PTC) cell lines.
• MIR141 is a known regulator of the TGFβ pathway, implicated in thyroid autoimmunity.

Purpose of the Study:

• To investigate MIR141 expression in archival thyroid malignancies.
• To determine if MIR141 can differentiate Hashimoto thyroiditis (HT) from papillary thyroid cancer (PTC).
• To explore the relationship between MIR141 and TGFβR1 expression in HT and PTC.

Main Methods:

• Quantitative RT-PCR analysis of MIR141 expression in 140 archival thyroid tissue samples (PTC, HT, controls).
• Laser capture microdissection for precise cell population isolation from formalin-fixed paraffin-embedded tissues.
• Analysis of TGFβR1 expression in a subset of HT and cPTC samples.

Main Results:

• Statistically significant differential expression of MIR141 was observed across thyroid tissue types (p < 0.05).
• MIR141 was significantly downregulated in Hashimoto thyroiditis (HT) samples compared to classic PTC (cPTC) and control thyrocytes.
• TGFβR1 expression was present in cPTC but absent in HT thyrocytes, suggesting a link to the TGFβ pathway.

Conclusions:

• Relative MIR141 expression levels can distinguish HT epithelium from cPTC and control epithelium.
• Downregulation of MIR141 in HT may involve its role in regulating the TGFβ pathway.
• MIR141 serves as a potential biomarker for differentiating thyroid conditions.